Myrexis Stock Price, News & Analysis (OTCMKTS:MYRX)

$0.05 0.00 (0.00 %)
(As of 02/25/2018 04:33 AM ET)
Previous Close$0.05
Today's RangeN/A
52-Week Range$0.02 - $0.10
Volume50 shs
Average Volume9,022 shs
Market Capitalization$1.63 million
P/E Ratio-0.11
Dividend YieldN/A
Beta-0.11

About Myrexis (OTCMKTS:MYRX)

Myrexi, Inc. is a development-stage company. The Company was a biopharmaceutical company that generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. In February 2012, it announced that the Company has suspended development activity on all of its preclinical and clinical programs and retained Stifel Nicolaus Weisel, an investment banking firm, to assist in reviewing and evaluating a full range of strategic alternatives to enhance shareholder value. The Company determines to pursue the acquisition of one or more commercial-stage biopharmaceutical assets, with the goal of building a commercial-stage biopharmaceutical company. The Company operates in pharmaceutical development and related research activities. The Company’s revenues were derived from research performed in the United States and, all of the Company’s long-lived assets are located in the United States.

Receive MYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:MYRX
CUSIPN/A
Phone+1-801-2147800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.112857142857143
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares34,480,000

Myrexis (OTCMKTS:MYRX) Frequently Asked Questions

What is Myrexis' stock symbol?

Myrexis trades on the OTCMKTS under the ticker symbol "MYRX."

Who are some of Myrexis' key competitors?

Who are Myrexis' key executives?

Myrexis' management team includes the folowing people:

  • Jonathan M. Couchman, President, Chief Executive Officer, Chief Financial Officer, Director (Age 45)
  • Andrea Kendell, Treasurer, Secretary (Age 40)
  • Michael Cooper Pearce, Independent Director (Age 51)
  • Steven D. Scheiwe, Independent Director (Age 55)

How do I buy Myrexis stock?

Shares of Myrexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Myrexis' stock price today?

One share of Myrexis stock can currently be purchased for approximately $0.05.

How big of a company is Myrexis?

Myrexis has a market capitalization of $1.63 million.

How can I contact Myrexis?

Myrexis' mailing address is 630 5th Ave Ste 2260, NEW YORK, NY 10111-2291, United States. The biopharmaceutical company can be reached via phone at +1-801-2147800 or via email at [email protected]


MarketBeat Community Rating for Myrexis (MYRX)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Myrexis (OTCMKTS:MYRX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Myrexis (OTCMKTS:MYRX) Earnings History and Estimates Chart

Earnings by Quarter for Myrexis (OTCMKTS:MYRX)

Myrexis (OTCMKTS MYRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2013Q3 2013($0.11)ViewN/AView Earnings Details
9/13/2012Q4 2012($0.16)ViewN/AView Earnings Details
5/10/2012Q3 2012($0.27)ViewN/AView Earnings Details
2/9/2012Q2 2012($0.29)ViewN/AView Earnings Details
11/9/2011Q1 2012($0.27)($0.33)ViewN/AView Earnings Details
9/8/2011Q4 2011($0.35)($0.31)ViewN/AView Earnings Details
5/10/2011Q3 2011($0.55)($0.50)ViewN/AView Earnings Details
2/9/2011Q2 2011($0.45)($0.31)ViewN/AView Earnings Details
11/9/2010Q1 2011($0.51)($0.40)ViewN/AView Earnings Details
9/9/2010Q4 2010($0.51)($0.31)ViewN/AView Earnings Details
5/17/2010Q3 2010($0.55)($0.56)ViewN/AView Earnings Details
2/16/2010Q2 2010($0.45)($0.60)ViewN/AView Earnings Details
11/12/2009Q1 2010($0.44)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Myrexis (OTCMKTS:MYRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Myrexis (OTCMKTS:MYRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2013special$2.862/19/20132/4/20132/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Myrexis (OTCMKTS MYRX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Myrexis (OTCMKTS MYRX) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Myrexis (OTCMKTS:MYRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Myrexis (OTCMKTS:MYRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Myrexis (OTCMKTS MYRX) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.